Keeps Biopharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22,044	18,777	4,106	23,625	37,197
Short-Term Investments	1,879	3,934	756.56	30	3,092
Trading Asset Securities	2,649	276.08	6,047	1,549	600.6
Cash & Short-Term Investments	26,571	22,988	10,910	25,203	40,889
Cash Growth	15.59%	110.71%	-56.71%	-38.36%	28.98%
Accounts Receivable	20,979	16,256	9,677	6,194	6,718
Other Receivables	288.65	460.57	1,925	212.39	332.01
Receivables	21,267	16,716	13,246	6,407	12,850
Inventory	31,524	20,436	5,328	1,602	2,246
Prepaid Expenses	633.76	828.01	113.06	53.6	42.96
Other Current Assets	22,386	9,746	17,169	10,044	7,315
Total Current Assets	102,382	70,714	46,766	43,310	63,342
Property, Plant & Equipment	43,636	35,068	28,376	10,062	10,365
Long-Term Investments	10,297	15,110	9,216	18,369	16,906
Goodwill	29,516	29,250	23,970	-	-
Other Intangible Assets	21,905	11,514	6,596	958.46	965.41
Long-Term Accounts Receivable	-	-	0	129.69	361.77
Long-Term Deferred Tax Assets	-	312.11	1,528	-	-
Other Long-Term Assets	24,573	5,021	826.23	6,367	1,462
Total Assets	233,917	166,989	117,279	85,559	93,401
Accounts Payable	3,915	5,925	2,765	630.13	768.35
Accrued Expenses	2,432	1,969	1,956	744.98	901.09
Short-Term Debt	35,066	41,640	47,904	28,124	26,755
Current Portion of Long-Term Debt	9,693	330.72	-	-	-
Current Portion of Leases	333.82	276.49	308.59	310.16	276.52
Current Income Taxes Payable	697.83	2,991	-	-	-
Other Current Liabilities	37,271	32,661	2,946	2,250	1,496
Total Current Liabilities	89,407	85,793	55,880	32,059	30,197
Long-Term Debt	47,347	13,427	-	-	-
Long-Term Leases	153.67	62.85	91.93	386.34	571.69
Pension & Post-Retirement Benefits	237.46	424.77	525.41	-	-
Long-Term Deferred Tax Liabilities	5,232	2,526	356.28	248.32	766.68
Other Long-Term Liabilities	10,037	1,340	1,846	597.55	978.75
Total Liabilities	152,415	103,574	58,699	33,291	32,514
Common Stock	10,039	9,374	9,374	9,374	9,268
Additional Paid-In Capital	61,665	36,806	67,866	67,691	64,242
Retained Earnings	-2,469	7,270	-23,631	-27,455	-15,188
Comprehensive Income & Other	-7,224	-3,317	3,627	3,462	2,704
Total Common Equity	62,011	50,134	57,236	53,072	61,026
Minority Interest	19,492	13,282	1,343	-804.49	-139.37
Shareholders' Equity	81,503	63,415	58,579	52,268	60,887
Total Liabilities & Equity	233,917	166,989	117,279	85,559	93,401
Total Debt	92,593	55,737	48,304	28,820	27,603
Net Cash (Debt)	-66,022	-32,749	-37,395	-3,617	13,286
Net Cash Growth	-	-	-	-	21.17%
Net Cash Per Share	-3366.81	-1735.34	-1987.66	-193.02	767.26
Filing Date Shares Outstanding	20.05	18.75	18.75	18.75	18.54
Total Common Shares Outstanding	20.05	18.75	18.75	18.75	18.54
Working Capital	12,974	-15,079	-9,114	11,251	33,145
Book Value Per Share	3092.30	2673.99	3052.82	2830.71	3292.31
Tangible Book Value	10,590	9,370	26,671	52,114	60,061
Tangible Book Value Per Share	528.07	499.75	1422.53	2779.59	3240.22
Land	20,923	13,663	12,710	3,022	3,022
Buildings	12,838	16,943	16,190	6,953	6,953
Machinery	22,997	20,991	15,312	3,343	3,283
Construction In Progress	5,345	2,886	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.